GlassScriptPhysician profile
Eduardo J Anorga
NPI 1235312752
$3,572.93
in general payments reported to CMS, 2019-2025
19 companies · $87.58 in 2025
The $87.58 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,044 · 2020: $431 · 2021: $798 · 2022: $577 · 2023: $402 · 2024: $233 · 2025: $87.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $722.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,692.96 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $514.70 | 2019-2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $287.02 | 2021-2022 | |
| Amarin Pharma, INC. | $221.57 | 2019 | |
| Amgen INC. | $148.64 | 2023 | Repatha, Otezla |
| Novo Nordisk INC | $132.72 | 2021-2022 | |
| Abbvie INC. | $115.69 | 2019-2022 | |
| Pfizer INC. | $96.41 | 2019-2023 | |
| Lilly USA, LLC | $87.64 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $77.18 | 2019 | |
| Esperion Therapeutics, INC. | $41.04 | 2020 | |
| Merck Sharp & Dohme LLC | $37.02 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.37 | 2019 | |
| Sun Pharmaceutical Industries INC. | $21.94 | 2021 | |
| Sanofi Pasteur INC. | $17.39 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $15.07 | 2020 | |
| Horizon Therapeutics Plc | $14.70 | 2020 | |
| Allergan, INC. | $13.05 | 2019 | |
| Nevro Corp. | $12.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eduardo Anorga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.